AbbVie Inc (ABBV)
176.93
+5.20
(+3.03%)
USD |
NYSE |
Nov 22, 16:00
177.07
+0.14
(+0.08%)
After-Hours: 20:00
AbbVie Cash from Financing (Quarterly): -3.072B for Sept. 30, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -3.072B |
| June 30, 2024 | -6.097B |
| March 31, 2024 | 10.82B |
| December 31, 2023 | -4.449B |
| September 30, 2023 | -2.661B |
| June 30, 2023 | -3.92B |
| March 31, 2023 | -6.192B |
| December 31, 2022 | -9.634B |
| September 30, 2022 | -5.518B |
| June 30, 2022 | -2.679B |
| March 31, 2022 | -6.972B |
| December 31, 2021 | -6.338B |
| September 30, 2021 | -3.643B |
| June 30, 2021 | -5.884B |
| March 31, 2021 | -3.174B |
| December 31, 2020 | -3.695B |
| September 30, 2020 | -2.814B |
| June 30, 2020 | -2.57B |
| March 31, 2020 | -2.422B |
| December 31, 2019 | 26.60B |
| September 30, 2019 | -441.00M |
| June 30, 2019 | -2.07B |
| March 31, 2019 | -5.383B |
| December 31, 2018 | -3.825B |
| September 30, 2018 | 916.00M |
| Date | Value |
|---|---|
| June 30, 2018 | -8.978B |
| March 31, 2018 | -2.509B |
| December 31, 2017 | -1.928B |
| September 30, 2017 | -810.00M |
| June 30, 2017 | -980.00M |
| March 31, 2017 | -1.794B |
| December 31, 2016 | -2.502B |
| September 30, 2016 | -1.371B |
| June 30, 2016 | 1.164B |
| March 31, 2016 | -1.219B |
| December 31, 2015 | -2.431B |
| September 30, 2015 | -1.056B |
| June 30, 2015 | 10.17B |
| March 31, 2015 | -930.00M |
| December 31, 2014 | -882.00M |
| September 30, 2014 | -719.00M |
| June 30, 2014 | -415.00M |
| March 31, 2014 | -1.277B |
| December 31, 2013 | -747.00M |
| September 30, 2013 | -613.00M |
| June 30, 2013 | -500.00M |
| March 31, 2013 | -1.582B |
| December 31, 2012 | 2.389B |
| September 30, 2012 | 2.244B |
| June 30, 2012 | -1.326B |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-9.634B
Minimum
Dec 2022
26.60B
Maximum
Dec 2019
-2.216B
Average
-3.669B
Median
Cash from Financing (Quarterly) Benchmarks
| Amgen Inc | -3.651B |
| Johnson & Johnson | -9.882B |
| Eli Lilly and Co | 211.30M |
| Merck & Co Inc | -2.425B |
| Pfizer Inc | -4.636B |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 5.447B |
| Cash from Investing (Quarterly) | -8.256B |
| Free Cash Flow | 15.62B |
| Free Cash Flow Per Share (Quarterly) | 2.933 |
| Free Cash Flow to Equity (Quarterly) | 4.753B |
| Free Cash Flow to Firm (Quarterly) | 5.642B |
| Free Cash Flow Yield | 4.98% |